|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gamat M and McNeel DG: Androgen
deprivation and immunotherapy for the treatment of prostate cancer.
Endocr Relat Cancer. 24:T297–T310. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hao L, Zhao Y, Li ZG, He HG, Liang Q,
Zhang ZG, Shi ZD, Zhang PY and Han CH: Tumor necrosis
factor-related apoptosis-inducing ligand inhibits proliferation and
induces apoptosis of prostate and bladder cancer cells. Oncol Lett.
13:3638–3640. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dorn DC, Kou CA, Png KJ and Moore MA: The
effect of cantharidins on leukemic stem cells. Int J Cancer.
124:2186–2199. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Nickolls LC and Teare D: Poisoning by
cantharidin. Br Med J. 2:1384–1386. 1954. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Huh JE, Kang KS, Chae C, Kim HM, Ahn KS
and Kim SH: Roles of p38 and JNK mitogen-activated protein kinase
pathways during cantharidin-induced apoptosis in U937 cells.
Biochem Pharmacol. 67:1811–1818. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Huan SK, Lee HH, Liu DZ, Wu CC and Wang
CC: Cantharidin-induced cytotoxicity and cyclooxygenase 2
expression in human bladder carcinoma cell line. Toxicology.
223:136–143. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Williams LA, Moller W, Merisor E, Kraus W
and Rosner H: In vitro anti-proliferation/cytotoxic activity of
cantharidin (Spanish Fly) and related derivatives. West Indian Med
J. 52:10–13. 2003.PubMed/NCBI
|
|
9
|
Xiong X, Wu M, Zhang H, Li J, Lu B, Guo Y,
Zhou T, Guo H, Peng R, Li X, et al: Atg5 siRNA inhibits autophagy
and enhances norcantharidin-induced apoptosis in hepatocellular
carcinoma. Int J Oncol. 47:1321–1328. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen YN, Chen JC, Yin SC, Wang GS, Tsauer
W, Hsu SF and Hsu SL: Effector mechanisms of norcantharidin-induced
mitotic arrest and apoptosis in human hepatoma cells. Int J Cancer.
100:158–165. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kok SH, Cheng SJ, Hong CY, Lee JJ, Lin SK,
Kuo YS, Chiang CP and Kuo MY: Norcantharidin-induced apoptosis in
oral cancer cells is associated with an increase of proapoptotic to
antiapoptotic protein ratio. Cancer Lett. 217:43–52. 2005.
View Article : Google Scholar
|
|
12
|
Su CC, Lee KI, Chen MK, Kuo CY, Tang CH
and Liu SH: Cantharidin induced oral squamous cell carcinoma cell
apoptosis via the JNK-regulated mitochondria and endoplasmic
reticulum stress-related signaling pathways. PLoS One.
11:e01680952016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yi SN, Wass J, Vincent P and Iland H:
Inhibitory effect of norcantharidin on K562 human myeloid leukemia
cells in vitro. Leuk Res. 15:883–886. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wiley SR, Schooley K, Smolak PJ, Din WS,
Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA,
et al: Identification and characterization of a new member of the
TNF family that induces apoptosis. Immunity. 3:673–682. 1995.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Srivastava RK: TRAIL/Apo-2L: Mechanisms
and clinical applications in cancer. Neoplasia. 3:535–546. 2001.
View Article : Google Scholar
|
|
16
|
Walczak H, Bouchon A, Stahl H and Krammer
PH: Tumor necrosis factor-related apoptosis-inducing ligand retains
its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing
chemotherapy-resistant tumor cells. Cancer Res. 60:3051–3057.
2000.PubMed/NCBI
|
|
17
|
Kelly MM, Hoel BD and Voelkel-Johnson C:
Doxorubicin pretreatment sensitizes prostate cancer cell lines to
TRAIL induced apoptosis which correlates with the loss of c-FLIP
expression. Cancer Biol Ther. 1:520–527. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ng CP, Zisman A and Bonavida B: Synergy is
achieved by complementation with Apo2L/TRAIL and actinomycin D in
Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: Role of
XIAP in resistance. Prostate. 53:286–299. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y and Zhang B: TRAIL resistance of
breast cancer cells is associated with constitutive endocytosis of
death receptors 4-5. Mol Cancer Res. 6:1861–1871. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Levine B, Mizushima N and Virgin HW:
Autophagy in immunity and inflammation. Nature. 469:323–335. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kondo Y, Kanzawa T, Sawaya R and Kondo S:
The role of autophagy in cancer development and response to
therapy. Nat Rev Cancer. 5:726–734. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Kondo Y and Kondo S: Autophagy and cancer
therapy. Autophagy. 2:85–90. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Moretti L, Yang ES, Kim KW and Lu B:
Autophagy signaling in cancer and its potential as novel target to
improve anticancer therapy. Drug Resist Updat. 10:135–143. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eisenberg-Lerner A, Bialik S, Simon HU and
Kimchi A: Life and death partners: Apoptosis, autophagy and the
cross-talk between them. Cell Death Differ. 16:966–975. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nazim UM, Moon JH, Lee JH, Lee YJ, Seol
JW, Eo SK, Lee JH and Park SY: Activation of autophagy flux by
metformin downregulates cellular FLICE-like inhibitory protein and
enhances TRAIL- induced apoptosis. Oncotarget. 7:23468–23481. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Nazim UM, Jeong JK and Park SY:
Ophiopogonin B sensitizes TRAIL-induced apoptosis through
activation of autophagy flux and downregulates cellular FLICE-like
inhibitory protein. Oncotarget. 9:4161–4172. 2017. View Article : Google Scholar
|
|
27
|
Elmallah MI and Micheau O: Marine drugs
regulating apoptosis induced by tumor necrosis factor-related
apoptosis-inducing ligand (TRAIL). Mar Drugs. 13:6884–6909. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wei RJ, Zhang XS and He DL:
Andrographolide sensitizes prostate cancer cells to TRAIL-induced
apoptosis. Asian J Androl. 20:200–204. 2018. View Article : Google Scholar :
|
|
29
|
Stuckey DW and Shah K: TRAIL on trial:
Preclinical advances in cancer therapy. Trends Mol Med. 19:685–694.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Honkanen RE: Cantharidin, another natural
toxin that inhibits the activity of serine/threonine protein
phosphatases types 1 and 2A. FEBS Lett. 330:283–286. 1993.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li HC, Xia ZH, Chen YF, Yang F, Feng W,
Cai H, Mei Y, Jiang YM, Xu K and Feng DX: Cantharidin inhibits the
growth of triple-negative breast cancer cells by suppressing
autophagy and inducing apoptosis in vitro and in vivo. Cell Physiol
Biochem. 43:1829–1840. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Ren Y, Zhang SW, Xie ZH, Xu XM, Chen LL,
Lou ZG, Weng GB and Yao XP: Cantharidin induces G2/M arrest and
triggers apoptosis in renal cell carcinoma. Mol Med Rep.
14:5614–5618. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hsiao YP, Tsai CH, Wu PP, Hsu SC, Liu HC,
Huang YP, Yang JH and Chung JG: Cantharidin induces G2/M phase
arrest by inhibition of Cdc25c and Cyclin A and triggers apoptosis
through reactive oxygen species and the mitochondriadependent
pathways of A375.S2 human melanoma cells. Int J Oncol.
45:2393–2402. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Han Z, Li B, Wang J, Zhang X, Li Z, Dai L,
Cao M and Jiang J: Norcantharidin inhibits SK-N-SH neuroblastoma
cell growth by induction of autophagy and apoptosis. Technol Cancer
Res Treat. 16:33–44. 2017. View Article : Google Scholar :
|
|
35
|
Poornima P, Weng CF and Padma VV: Neferine
from Nelumbo nucifera induces autophagy through the inhibition of
PI3K/Akt/mTOR pathway and ROS hyper generation in A549 cells. Food
Chem. 141:3598–3605. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Klionsky DJ and Emr SD: Autophagy as a
regulated pathway of cellular degradation. Science. 290:1717–1721.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Park MH, Kim JH, Chung YH and Lee SH:
Bakuchiol sensitizes cancer cells to TRAIL through ROS- and
JNK-mediated upregulation of death receptors and downregulation of
survival proteins. Biochem Biophys Res Commun. 473:586–592. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Liu YJ, Lin YC, Lee JC, Kuo SC, Ho CT,
Huang LJ, Kuo DH and Way TD: CCT327 enhances TRAIL-induced
apoptosis through the induction of death receptors and
downregulation of cell survival proteins in TRAIL-resistant human
leukemia cells. Oncol Rep. 32:1257–1264. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sophonnithiprasert T, Nilwarangkoon S,
Nakamura Y and Watanapokasin R: Goniothalamin enhances
TRAIL-induced apoptosis in colorectal cancer cells through DR5
upregulation and cFLIP downregulation. Int J Oncol. 47:2188–2196.
2015. View Article : Google Scholar : PubMed/NCBI
|
